| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/29/2006 | WO2006040129A3 Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography |
| 06/29/2006 | WO2006037124A3 Container with constrained quality maintenance agent |
| 06/29/2006 | WO2006009696A3 Anticoagulant contrast media |
| 06/29/2006 | US20060141545 Cancer treatment kits using antibodies to aminophospholipids |
| 06/29/2006 | US20060140941 Growth differentiation factor-3 |
| 06/29/2006 | US20060140871 Magnetic resonance imaging of prostate cancer |
| 06/29/2006 | US20060140870 Method for assessing tumor response to cancer treatment |
| 06/29/2006 | US20060140869 Polymeric contrast agents for use in medical imaging |
| 06/29/2006 | US20060140868 Method of preparation of biomagnetic nanoparticles coated with a noble metal layer |
| 06/29/2006 | US20060140867 Coated stent assembly and coating materials |
| 06/29/2006 | US20060140866 measuring the accuracy of NMDA injection into a mouse brain comprising co-injecting methylene blue |
| 06/29/2006 | US20060140865 Nano-micelle carrier used in near infrared image detection and detection method thereof |
| 06/29/2006 | US20060140864 Oral contrast and method of producing the oral contrast |
| 06/29/2006 | US20060140863 Production of a dye agent for colouring cells in the human or animal body |
| 06/29/2006 | US20060140862 Fish hatching method and apparatus |
| 06/29/2006 | US20060140861 Method for diagnosing lactose intolerance and diagnostic kit for performing the method |
| 06/29/2006 | US20060140860 Computational knowledge model to discover molecular causes and treatment of diabetes mellitus |
| 06/29/2006 | US20060140858 Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 06/29/2006 | US20060138381 Latex polymer particles containing fluorescent substance or contrast medium and process for producing the same |
| 06/29/2006 | US20060137602 Preparation of iodixanol |
| 06/28/2006 | EP1673473A1 Use of genetic polymorphisms that associate with efficacy of treatment of inflammatory disease |
| 06/28/2006 | EP1673109A1 Inherently radiopaque polymeric products for embolotherapy |
| 06/28/2006 | EP1673108A2 Methods and compositions for ultrasound imaging of apoptosis |
| 06/28/2006 | EP1372694B1 Liposome targeting of matrix metalloproteinase inhibitors |
| 06/28/2006 | CN1795198A Glycerophosphocholine and its derivatives for medical imaging of neuropsychiatric disorders |
| 06/28/2006 | CN1795015A Optically pure and enriched isomers of chelating ligands and contrast agents |
| 06/28/2006 | CN1792376A Naloxone eye drops |
| 06/28/2006 | CN1792334A System and method of perfusion imaging and ultrasonic control releasing based-on capsule microbubble |
| 06/28/2006 | CN1261416C Perfuoroalkylamide, prodn. and use in diagnostics thereof |
| 06/28/2006 | CN1261165C Preparation for prophylaxis of restenosis |
| 06/27/2006 | USRE39146 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof |
| 06/27/2006 | US7067293 environmentally modified, extracted chlorosomes of the thermophilic green photosynthetic bacterium Chloroflexus aurantiacus are coupled to a semiconductor silicon photovoltaic cell to enhance performance and response across the blue light and infrared spectrums; photosensitive devices |
| 06/27/2006 | US7067276 administering a cytotoxic compound of porphyrin complexed with a radioactive metal to a mammal; treating arteriosclerotic lesions; radioactive metal is cytotoxic to cells in and surrounding the plaque |
| 06/27/2006 | US7067261 Methods and compositions for treatment of central nervous system disorders |
| 06/27/2006 | US7067121 Grafting heart tissue; closure of heart defect |
| 06/27/2006 | US7067113 Antiinflammatory agents; anticancer agents; congestive heart failure; genetic disorders; contacting with dpamine receptors; determination binding; calibration |
| 06/27/2006 | US7067112 Peptaibol antibiotics, synthesized from Acremonium tubakii, during fermentation and released into culture medium, containing high content of beta-aminobutyric acid and isovaline |
| 06/27/2006 | US7067111 Antitumor agents; chelate compounds |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/22/2006 | WO2006066118A2 Contextual fear test for predicting efficacy of alzheimer immunotherapeutic treatment |
| 06/22/2006 | WO2006065943A2 In-vivo monitoring of circulating apoptotic cells |
| 06/22/2006 | WO2006065146A2 Fluorescent contrast agents |
| 06/22/2006 | WO2006064451A2 Targeting contrast agents or targeting therapeutic agents for molecular imaging and therapy |
| 06/22/2006 | WO2006064227A1 Magnetic resonance contrast media |
| 06/22/2006 | WO2006038184A3 Compounds, kits and methods for use in medical imaging |
| 06/22/2006 | WO2006001806A3 Method for non-invasive thermometry using elastin-like polypeptide conjugates |
| 06/22/2006 | WO2005117996A3 Immune response assessment method |
| 06/22/2006 | WO2005087272A3 X-ray contrast formulation comprising a mixture of iodinated monomer and dimer |
| 06/22/2006 | WO2005020905A3 Echogenic coatings with overcoat |
| 06/22/2006 | US20060135490 Targeting mPGES-1 as a treatment for inflammation which avoids cardiovascular risk |
| 06/22/2006 | US20060134206 Oral compositions for treatment of diseases |
| 06/22/2006 | US20060134005 In-vivo monitoring of circulating apoptotic cells |
| 06/22/2006 | US20060134004 Methods and apparatus for detection of carotenoids in macular tissue |
| 06/22/2006 | US20060134002 Labelling with fluorescent probes, illuminating, and detecting |
| 06/22/2006 | US20060134001 Conjugated infrared fluorescent substances for detection of cell death |
| 06/22/2006 | US20060134000 Method for producing a computed tomography display of tissue structures by applying a contrast medium |
| 06/22/2006 | US20060133999 Method for the diagnosis of Helicobacter pylori infection, and a diagnostic kit for performing the method |
| 06/22/2006 | US20060133998 Method for the use of [11C] carbon monoxide in labeling synthesis of 11C-labelled amides using metal amides and photo-induced free radical carbonylation |
| 06/22/2006 | US20060133997 A method of demonstrating draining activity of a cosmetic and/or dermocosmetic treatment on the superficial dermis and/or the epidermis |
| 06/22/2006 | US20060133996 Method and apparatus for determining effectiveness of sunscreens and other skin preparations in shielding human skin from uva radiation |
| 06/22/2006 | CA2591534A1 Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 06/22/2006 | CA2587589A1 Engineered antibodies and immunoconjugates |
| 06/21/2006 | EP1672072A2 Cloning and characterisation of the gene flbA of H. pylori; production of flagella-free strains |
| 06/21/2006 | EP1671656A1 Gels composed of glycols and/or polyols and PVP as in-vivo biocompatible acoustic couplants |
| 06/21/2006 | EP1670512A2 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 06/21/2006 | EP1670413A2 Method of reducing visceral fat by increasing levels of insulin-like growth factor-i (igf-i) |
| 06/21/2006 | EP1670350A2 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 06/21/2006 | EP1670347A2 Fluorescence polarization imaging devices and methods |
| 06/21/2006 | EP1284952B1 Substituted chalcones as therapeutic compounds |
| 06/21/2006 | EP1140170B1 Antibody fragments for the topical treatment of ocular diseases |
| 06/21/2006 | EP0912198B1 Immunoliposomes that optimize internalization into target cells |
| 06/21/2006 | CN1791440A Medical devices with enhanced ultrasonic visibility |
| 06/20/2006 | US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 06/15/2006 | WO2006063106A1 Contrast agent coated medical device |
| 06/15/2006 | WO2006062233A1 A staining composition for staining an ophthalmic membrane |
| 06/15/2006 | WO2006062135A1 Diagnostic for mental disease |
| 06/15/2006 | WO2005120589A3 Contrast agent comprising alginate and an isotope or paramagnetic ion |
| 06/15/2006 | WO2005084715A3 Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy |
| 06/15/2006 | US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls. |
| 06/15/2006 | US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells |
| 06/15/2006 | US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin |
| 06/15/2006 | US20060128736 Camptothecin-carboxylate formulations |
| 06/15/2006 | US20060128683 Novel use of porphyrin derivatives |
| 06/15/2006 | US20060127884 Toll-like receptor 9 modulators |
| 06/15/2006 | US20060127470 Use of buckysome or carbon nanotube for drug delivery |
| 06/15/2006 | US20060127349 Administering water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/15/2006 | US20060127316 Polyols and PVP as in vivo biocompatible acoustic coupling media |
| 06/15/2006 | US20060127315 Methods of treating humans undergoing injection of a contrast agent |
| 06/15/2006 | US20060127314 Method and arrangement for producing contrast agent for magnetic resonance imaging |
| 06/15/2006 | US20060127313 Method and apparatus for producing contrast agents for magnetic resonance imaging |
| 06/15/2006 | US20060127312 Notch signaling in long-term memory formation |
| 06/15/2006 | US20060127306 Radioactively labelled amino acid analogues, their preparation and use |
| 06/14/2006 | EP1669092A1 Preparation for the prophylaxis of restenose |
| 06/14/2006 | EP1668424A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |
| 06/14/2006 | EP1667735A2 Inhibition of inward sodium currents in cancer |
| 06/14/2006 | EP1667734A2 Optical imaging of colorectal cancer |
| 06/14/2006 | EP1667733A1 A method of evaluating organ function |
| 06/14/2006 | EP1667716A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |